Most people with diabetes in developed countries are above the age of retirement. However, in developing countries and especially those in which there has been major changes in lifestyle, those most frequently diagnosed with diabetes are of a younger demographic, typically aged between 35 and 64.
China, India, Africa and South East Asia are perhaps the most dramatic example of these societal shifts and they also demonstrate the important role played by lifestyle factors and the potential that early detection has for reversing the global epidemics such as diabetes, heart disease and obesity.
Given this global backdrop, several health/wellness platforms have emerged to help diagnose, manage and treat diabetes. However several white label medical devices have emerged that not only offer chronic disease management services, but also a range of hardware software integrations.
One of these is Dnurse, a Beijing based medtech startup that specializes in providing diabetes platforms, pharmaceuticals and insurers with insulin dosage monitors, blood glucose meters, and full spectrum health terminals that monitor ECG, blood pressure and blood / glucose levels in real time.
However, the team at Dnurse recognized early that medical devices alone are not sufficient. Rather, chronic disease treatments must be coupled with software to deliver real time analysis. To this end, Dnurse has also developed the Dnurse APP to guide diabetics on a daily basis through recorded blood glucose levels, insulin dosages, dietary intake, physical activity, and blood pressure. At the heart of the Dnurse app is the Intelligent Decision Support System, a recommendation engine based on 10,000 diabetic scenarios from which users are warned in advance of complications arising from inconsistent blood / glucose levels and blood pressure anomalies. The IDSS also provides daily reminders and notifications to Dnurse users about dietary, exercise and medication.
Therefore, Dnurse also provides a host of white label medical devices to pharmacies, insurers, and pharmaceutical companies white label including;
InsulinKTM: Automatically uploads insulin dosage data from the insulin pump through speech recognition, noise cancelling and bluetooth features.
Smart Glucose Meter: Anti-interference and the longest lasting glucose meter on the market with 4000 uses and 5 year life span.
Multi-parametric: Deployed in pharmacies, the multi-parameter health terminal is designed to monitor ECG, blood pressure and blood / glucose levels in real time.
Despite considerable advancement in medical devices, there is lack of integrated hardware software solutions for diabetics. Dnurse;s approach of “APP + Device” consists of a series of smart medical devices, APPs, and services is helping to address this gap for diabetes management providers worldwide.